StockData
Microbot Medical Inc. logo

Microbot Medical Inc. (MBOT) stock

MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.98−0.05 (-4.98%)

Close on Nov 13, 2026Market cap $65.73MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026

Valuation

Market cap
$65.73M
P/E ratio
–
Price to sales
–
Price to book
1.04
Dividend yield
–
Free cash flow yield
-29.81%

Fundamentals

Net income
-$18.60M
EPS, diluted
-$0.27
Free cash flow
-$19.60M
Book value per share
$0.94
Diluted shares
67M

Trading

Previous close
$1.03
Open
$1.04
Day's range
$0.95 – $1.05
Volume
1,163,780
Average volume (20 days)
921,899
Beta (5 years)
1.47
52-week range
$0.93 – $2.85
RSI (14 days)
40.3
Volatility (1 year)
69.6%
Relative volume
1.65×
WACC
12.5%

Market cap history

Month-end market cap since 2011, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodMBOTS&P 500DifferenceMBOT per yearS&P 500 per year
1 month-4.0%-3.0%−1.0 pts
3 months-41.7%-2.8%−39.0 pts
Year to date-51.1%+11.5%−62.6 pts
1 year-50.8%+13.5%−64.3 pts
3 years-27.0%+77.7%−104.7 pts-9.9%+21.1%
5 years-85.9%+72.6%−158.5 pts-32.4%+11.5%
10 years-99.3%+308.2%−407.5 pts-39.5%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

–

Gross profit

–

Operating income

-$21.14M

Net income

-$18.60M

EPS, diluted

-$0.27

Free cash flow

-$19.60M
Reported periodTrailing twelve months

Press releases

Releases Microbot Medical filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Microbot Medical

Surgical & Medical Instruments & Apparatus

Microbot Medical Inc. is a medical device company that researches, designs, and develops robotic endoluminal surgical systems. The company focuses on developing its proprietary robotic surgical platform, known as the LIBERTY Endovascular Robotic Surgical System, which is designed for use in endovascular procedures. Microbot aims to serve healthcare providers, medical facilities, and surgical specialists conducting minimally invasive interventions.

Company profile, executives and history

Microbot Medical stock: common questions

What is Microbot Medical's stock price?

MBOT closed at $0.98 on Nov 13, 2026, down 4.98% on the day. Over the past 52 weeks it traded between $0.93 and $2.85.

What is Microbot Medical's market cap?

Microbot Medical was worth $65.73M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is MBOT's P/E ratio?

Microbot Medical lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.27), so it has no meaningful P/E ratio.

Does Microbot Medical pay a dividend?

No. Microbot Medical has not paid a cash dividend over the last twelve months.

How has MBOT stock performed over the past year?

Including dividends, MBOT returned -50.8% over the past year, against +13.5% for the S&P 500.

How many MBOT shares are sold short?

6M shares were sold short at the latest FINRA report, 9.44% of the float, or 7.8 days of average trading volume.

Who are Microbot Medical's competitors?

Companies most similar to Microbot Medical by business, industry and size include GUTS, PYPD, SSII, PRCT, LNSR.

See a number that looks wrong?